Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 18, 906-910, September 1, 1958]
© 1958 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molomut, N.
Right arrow Articles by Lazere, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molomut, N.
Right arrow Articles by Lazere, F.

Host-induced Alterations in Strain Specificity of Sarcoma I in Mice: Reversibility of the Change*

Norman Molomut, Ludmilla Skaredoff, Edith Ratner and Florence Lazere

( Waldemar Medical Research Foundation, Port Washington, N.Y.)

1. The reversibility of the alteration in the strain specificity of Sarcoma I, induced by passage through actively immunized C57BL/6 mice, has been studied.
2. The altered Sarcoma I (Sarcoma I/Mo) was serially transplanted during a 2-year period in normal adult mice, both sexes, in 533 C3H, 457 BALB/c, and 364 C57BL/6 mice.
3. In each of the strains studied the adapted Sarcoma I/Mo established itself in a relatively constant "take" ratio, i.e., 92.3 per cent in C3H, 92.6 per cent in BALB/c, and 73.8 per cent in C57BL/6.
4. Sarcoma I/Mo continued to change when resident as a homotransplant, as evidenced by the acquisition of capacity to "take" in C57BL/6 mice only after residence in C3H and in BALB/c serial passages.
5. The acquired homotransplantability was reversible: A strain specificity was gradually regained when the Sarcoma I/Mo was returned to and carried in serial passages in A strain mice.
6. Given a changing, adverse, but nonlethal environment a mouse cancer graft, Sarcoma I, was induced to acquire several new compatibilities.

* Supported in part by grants from the National Institutes of Health, Department of Health, Education and Welfare (Grant C-1658 C5); the Vernay Foundation, Yellow Springs, Ohio; and the Louis A. and Hazel Breskin Foundation, Chicago, Illinois.

A portion of these data was reported at the American Association for Cancer Research, April, 1957.

Received 3/24/58.


This article has been cited by other articles:


Home page
ScienceHome page
B. B. Jacobs and D. E. Uphoff
Immunologic Modification: A Basic Survival Mechanism
Science, August 16, 1974; 185(4151): 582 - 587.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1958 by the American Association for Cancer Research.